Accreditation Statements

WORLDSymposium™ Ethical MedTech EU Compliance


EthicalMedTech is a platform, supported by MedTech Europe, dedicated to ethics and compliance projects in the European MedTech industry.

This event will be submitted to EthicalMedTech later this year.

WORLDSymposium 2021, 2022, 2023, 2024, 2025 and 2026 were found to be compliant in accordance with the principles and standards set out in the MedTech Europe Code of Ethical Business Practice.

WORLDSymposium 2027 Genetic Counselor CEUs

This event will be submitted to the National Society of Genetic Counselors (NSGC) for the approval of Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification. Approval for the requested CEUs and Contact Hours is currently pending.

CEUs for Genetic Counselors do not apply for the On Demand program.

Genetic Counselors must complete an online evaluation. Instructions will be provided in the mobile app. The online evaluation should be completed within 2 weeks post-conference, and must include your NSGC number. Please note, you are required to pay the NSGC Fee of $35 at the time of registration in order to obtain NSGC Credit; if you did not pay the fee, you may not receive the NSGC CEU Credits. Upon completion of the online Evaluation, you will receive a Certificate of Completion. The official Certificate of Credit will come directly from NSGC. If you have any questions, contact Drew Saterdalen at: drew@worldsymposia.org.

2027 ACCME & ANCC Accreditation

WORLDSymposium 2027 is jointly provided by Medical Education Resources and WORLDSymposium. CE credit is available to Live and On Demand attendees.

Program Overview
The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases. This symposium is designed to help researchers, clinicians, registered nurses, and genetic counselors better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.

Target Audience:
This activity is intended for healthcare professionals involved in the screening, diagnosis, management, and treatment of lysosomal diseases affecting both children and adults, with research and clinically relevant information geared specifically to the following professionals:

  • Medical and clinical geneticists; genetic counselors; pediatricians; neurologists; psychologists; nurse practitioners; physician assistants; registered nurses; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, lysosomal diseases.
  • Laboratory directors and technicians involved in genetic testing.
  • Researchers involved in lysosomal disorders and treatments.
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences with a focus on lysosomal diseases.
  • Any healthcare and public health professionals who have an interest in medical and clinical genetics and genomics in the area of lysosomal diseases.
  • Advocates for patients with lysosomal diseases and their families.

NOTE: Adult patients and adult family members are welcome to attend the educational sessions, however the content is intended for clinicians and researchers, and not targeted toward patients. Attendance for patients and family members is offered as an opportunity to obtain information pertinent to their personal journey and to connect with leading researchers and clinicians. Children under 18 are not allowed in any session.

Educational Objectives:
At the completion of this program, the participant should be able to:

  • Identify the key diagnostic features of lysosomal diseases.
  • Utilize recent diagnostic tests for lysosomal diseases.
  • Compare the relative advantages and disadvantages of each therapy currently available.
  • Identify unmet needs of each disease being discussed.
  • Formulate new research ideas for these lysosomal diseases.
Jointly Accredited Provider Logo

Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources and WORLDSymposium. Medical Education Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional Continuing Education (IPCE):

This activity was planned by and for the healthcare team, and learners will receive Interprofessional continuing Education (IPCE) credit for learning and change.

Physician Continuing Education:
Medical Education Resources designates this live activity for AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education:
This activity is eligible for ANCC credit, see final CNE activity announcement for specific details.

California Board of Registered Nursing:
This activity is eligible for California Board of Registered Nursing contact hours, see final CNE activity announcement for specific details.

CE for AMA and ANCC will be available for the On Demand program.

Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

Americans with Disabilities Act:

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Amanda Thomas prior to the live event at athomas@etherio.com.